UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CS2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency

Cancer science, 2017-03, Vol.108 (3), p.469-477

2017

Volltextzugriff (PDF)

Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate transcription of adiponectin

Phytotherapy research, 2008-10, Vol.22 (10), p.1400-1403

2008

Volltextzugriff (PDF)

Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells

Biomedicine & pharmacotherapy, 2014-05, Vol.68 (4), p.483-491

2014

Volltextzugriff (PDF)

Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPARγ

PPAR Research, 2017-01, Vol.2017, p.4313561-16

2017

Volltextzugriff (PDF)

Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment

MedChemComm, 2014-01, Vol.5 (12), p.1789-1796

2014

Volltextzugriff (PDF)

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

Cancer chemotherapy and pharmacology, 2012-04, Vol.69 (4), p.901-909

2012

Volltextzugriff (PDF)

The PPARα/γ dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats

British journal of pharmacology, 2006-07, Vol.148 (5), p.610-618

2006

Volltextzugriff (PDF)

Advances in targeting histone deacetylase for treatment of solid tumors

Journal of hematology and oncology, 2024-05, Vol.17 (1), p.37-20, Article 37

2024

Volltextzugriff (PDF)

Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas

Cancer chemotherapy and pharmacology, 2012-06, Vol.69 (6), p.1413-1422

2012

Volltextzugriff (PDF)

A New Retinoid-Like Compound That Activates Peroxisome Proliferator-Activated Receptors and Lowers Blood Glucose in Diabetic Mice

Biological and Pharmaceutical Bulletin, 2005, Vol.28(7), pp.1192-1196

2005

Volltextzugriff (PDF)

Relationship between Cerebral Hypoxic Tissue Volume and Prognosis after Stroke

European neurology, 2010-01, Vol.63 (1), p.52-59

2010

Volltextzugriff (PDF)

CS 2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency

Cancer science, 2017-03, Vol.108 (3), p.469-477

2017

Volltextzugriff (PDF)

Peroxisome Proliferator-Activated Receptor-γ Transcriptionally Up-Regulates Hormone-Sensitive Lipase via the Involvement of Specificity Protein-1

Endocrinology (Philadelphia), 2006-02, Vol.147 (2), p.875-884

2006

Volltextzugriff (PDF)

Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves' disease after 131Iodine treatment

Journal of radiation research, 2016-11, Vol.57 (6), p.702-708

2016

Volltextzugriff (PDF)

A selective retinoid with high activity against an androgen‐resistant prostate cancer cell type

International journal of cancer, 1999-01, Vol.80 (2), p.272-278

1999

Volltextzugriff (PDF)

Phthalide lactones from Ligusticum chuanxiong inhibit lipopolysaccharide-induced TNF-α production and TNF-α-mediated NF-kappa B activation

Planta medica, 2005-09, Vol.71 (9), p.808-813

2005

Volltextzugriff (PDF)

Retinoids Selective for Retinoid X Receptor Response Pathways

Science (American Association for the Advancement of Science), 1992-12, Vol.258 (5090), p.1944-1946

1992

Volltextzugriff (PDF)

Construction of a virtual combinatorial library using SMILES strings to discover potential structure-diverse PPAR modulators

European journal of medicinal chemistry, 2005-07, Vol.40 (7), p.632-640

2005

Volltextzugriff (PDF)

Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo

Nature medicine, 1997-06, Vol.3 (6), p.686-690

1997

Volltextzugriff (PDF)

Selective Activation of an Apoptotic Retinoid Precursor in Macrophage Cell Lines

The Journal of biological chemistry, 1998-08, Vol.273 (33), p.20852-20859

1998

Volltextzugriff (PDF)

3D QSAR studies on peroxisome proliferator-activated receptor gamma agonists using CoMFA and CoMSIA

Journal of molecular modeling, 2004-06, Vol.10 (3), p.165-177

2004

Volltextzugriff (PDF)

Retinoic acid receptors and retinoid X receptor-α down-regulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity

Molecular endocrinology (Baltimore, Md.), 1993, Vol.7 (10), p.1347-1356

1993

Volltextzugriff (PDF)

Nuclear Retinoid Receptors and Their Mechanism of Action

Vitamins and Hormones, 1994, Vol.49, p.327-382

1994

Volltextzugriff (PDF)

Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARα selective activators

Bioorganic & medicinal chemistry letters, 2004-07, Vol.14 (13), p.3507-3511

2004

Volltextzugriff (PDF)

Preliminary study on the value of 99Tc(m)-HL91 imaging in predicting sensitivity to radiotherapy in patients with nasopharyngeal carcinoma

Zhōnghuá zhŏngliú zázhì, 2007-05, Vol.29 (5), p.369

2007

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(165)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CS2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency

Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate transcription of adiponectin

Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells

Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPARγ

Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

The PPARα/γ dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats

Advances in targeting histone deacetylase for treatment of solid tumors

Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas

A New Retinoid-Like Compound That Activates Peroxisome Proliferator-Activated Receptors and Lowers Blood Glucose in Diabetic Mice

Relationship between Cerebral Hypoxic Tissue Volume and Prognosis after Stroke

CS 2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency

Peroxisome Proliferator-Activated Receptor-γ Transcriptionally Up-Regulates Hormone-Sensitive Lipase via the Involvement of Specificity Protein-1

Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves' disease after 131Iodine treatment

A selective retinoid with high activity against an androgen‐resistant prostate cancer cell type

Phthalide lactones from Ligusticum chuanxiong inhibit lipopolysaccharide-induced TNF-α production and TNF-α-mediated NF-kappa B activation

Retinoids Selective for Retinoid X Receptor Response Pathways

Construction of a virtual combinatorial library using SMILES strings to discover potential structure-diverse PPAR modulators

Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo

Selective Activation of an Apoptotic Retinoid Precursor in Macrophage Cell Lines

3D QSAR studies on peroxisome proliferator-activated receptor gamma agonists using CoMFA and CoMSIA

Retinoic acid receptors and retinoid X receptor-α down-regulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity

Nuclear Retinoid Receptors and Their Mechanism of Action

Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARα selective activators

Preliminary study on the value of 99Tc(m)-HL91 imaging in predicting sensitivity to radiotherapy in patients with nasopharyngeal carcinoma

Suchergebnisse filtern